Goodwin covers a wide array of deal and merger litigation cases, working closely with their M&A transactional team to successfully engage in risk mitigation. The team litigates at state and federal courts alongside arbitrating M&A disputes domestically and internationally. Boston-based Caroline Bullerjahn focuses on life sciences disputes, while New York-based Douglas Flaum handles US and cross-border commercial, securities, and real estate matters. Deborah Birnbach, who works out of Boston, and San Francisco-based Jonathan Shapiro both advise on a full range of securities and shareholder litigation matters. Another key name is Jordan Weiss, who is based in New York.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Key clients
- Former Officer and Director of Cedar Realty Trust, Inc.
- Shareholders of Nangate Denmark Aps
- BSI3 Menu Buyer, Inc. (Beyond Menu)
- Shareholder Representative Services LLC
- Financial-Information-Technologies, LLC and Fintech Holdco, LLC
- Renesas Electronics Corporation
- Webster Equity Partners, LP
- Cardiovascular Associates of America, LLC
- Infusion Services Management, LLC
- Wealth Enhancement Group
- Benchmark Capital
- Kingswood Capital Management, LLC
Work highlights
Advised certain members of the board of directors of Zuora, comprising of a special committee responsible for overseeing and approving Zuora’s US$1.7 billion merger with Silver Lake Group LLC.
Represented Benchmark Capital and achieved a full defense victory for Benchmark Capital and its partner, after a two-week California bench trial brought by shareholders and co-founders of Art.com.
Advised Webster Equity Partners, LP; Cardiovascular Associates of America, LLC and secured the voluntary dismissal of all claims against Webster and CVAUSA in high-stakes trade secret and deceptive business practices litigation filed by a major Orlando-based health care system.
Practice head
Caroline Bullerjahn; Deborah Birnbach; Douglas Flaum; Jonathan Shapiro; Jordan Weiss